| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/29/2001 | US6238866 Panel of double-stranded oligonucleotide probes including hypervariable number of tandem repeat sequences immobilized onto a solid support; hybridizes to allele which is fragment of epstein-barr virus genome |
| 05/29/2001 | US6238864 Simple, sensitive in vitro detection of binding of analyte to capturing agent positioned on dna through production of reporter rna; high molecular weight analytes; can be automated |
| 05/29/2001 | US6238863 Materials and methods for indentifying and analyzing intermediate tandem repeat DNA markers |
| 05/29/2001 | US6238862 Methods for testing oligonucleotide arrays |
| 05/29/2001 | US6238861 Neurofibromatosis gene |
| 05/29/2001 | US6238860 Amino acid sequence of polypeptide which binds b19-polypeptide; detection in sample; removal from solution; testing transfusion blood supplies |
| 05/29/2001 | US6238857 Method for analyzing intracellular components |
| 05/29/2001 | US6238669 Proteins encoded by chicken anemia virus DNA and diagnostic kits and vaccines employing said proteins |
| 05/29/2001 | US6238666 Polypeptide |
| 05/29/2001 | US6238624 A self-addressable, self-assembling microelectronic device is designed and fabricated to actively carry out and control multi-step and multiplex molecular biological reactions in microscopic formats. |
| 05/29/2001 | CA2325278A1 Nucleic acid-immobilized substrate |
| 05/29/2001 | CA2306194C Chromosome 9 and progressive rod-cone degeneration disease genetic markers and assays |
| 05/29/2001 | CA2225450C Interleukin-1 receptor-associated protein kinase and assays |
| 05/29/2001 | CA2171638C The semaphorin gene family |
| 05/25/2001 | WO2001037291A1 Magnetic glass particles, method for their preparation and uses thereof |
| 05/25/2001 | WO2001037194A2 Crystallizable compositions comprising a caspase-7 |
| 05/25/2001 | WO2001037191A2 Method for manipulating protein or dna sequence data (in order to generate complementary peptide ligands) |
| 05/25/2001 | WO2001036979A2 Placental human neurokinin b precursor |
| 05/25/2001 | WO2001036977A2 Identification of disease markers involving mass-based-separation |
| 05/25/2001 | WO2001036976A2 Novel diagnosis and treatment for atherosclerosis |
| 05/25/2001 | WO2001036970A1 Method for assessing genotoxicity of a compound |
| 05/25/2001 | WO2001036965A2 Electric substance detectors comprising cellular material |
| 05/25/2001 | WO2001036963A2 Method for detecting noxious substances using plant cell suspensions |
| 05/25/2001 | WO2001036958A1 Film based addressable programmable electronic matrix articles and methods of manufacturing and using the same |
| 05/25/2001 | WO2001036955A1 Biosensor |
| 05/25/2001 | WO2001036954A1 Biosensor |
| 05/25/2001 | WO2001036953A1 Biosensor, method of forming thin-film electrode, and method and apparatus for quantitative determination |
| 05/25/2001 | WO2001036943A1 Method for estimating measurement of absorbance and apparatus for estimating measurement of absorbance |
| 05/25/2001 | WO2001036939A2 Method for the automatic analysis of microscope images |
| 05/25/2001 | WO2001036688A1 Method for detecting replication competent viruses in the sera of subjects receiving gene therapy |
| 05/25/2001 | WO2001036687A2 Simultaneous hybridization/priming for snp analysis |
| 05/25/2001 | WO2001036686A2 Genomic polymorphism for predicting therapeutic response |
| 05/25/2001 | WO2001036685A2 Differential gene expression in cancer |
| 05/25/2001 | WO2001036684A2 Mammalian toxicological response markers |
| 05/25/2001 | WO2001036683A2 Method for rapid and accurate identification of microorganisms |
| 05/25/2001 | WO2001036682A2 Long oligonucleotide arrays |
| 05/25/2001 | WO2001036681A2 Immunological detection of rna:dna hybrids on microarrays |
| 05/25/2001 | WO2001036680A2 METHODS OF PREPARING cRNA |
| 05/25/2001 | WO2001036679A2 METHODS FOR GENERATING SINGLE STRANDED cDNA FRAGMENTS |
| 05/25/2001 | WO2001036678A1 A method to evaluate cytokine function |
| 05/25/2001 | WO2001036677A1 Development of method for screening physiologically active pyrrole imidazole derivative |
| 05/25/2001 | WO2001036676A2 Security system |
| 05/25/2001 | WO2001036675A2 Cd36 polymorphisms |
| 05/25/2001 | WO2001036674A2 Diagnostic methods for detection of prostate disorders |
| 05/25/2001 | WO2001036673A2 Test for micro-organisms |
| 05/25/2001 | WO2001036672A2 Method for detecting pcr products, pcr detection kit and device to be used in such a method |
| 05/25/2001 | WO2001036670A2 Diagnosis kit, method and microarray for determining human detoxification capacity |
| 05/25/2001 | WO2001036669A2 Method for the controlled implementation of complex pcr amplifications |
| 05/25/2001 | WO2001036668A1 Colour labelled oligonucleotide for labelling a nucleic acid molecule |
| 05/25/2001 | WO2001036667A1 Combinatorial and automatic detection method of target gene, and a detector using the method |
| 05/25/2001 | WO2001036666A1 Apparatus and method for assaying coagulation in fluid samples |
| 05/25/2001 | WO2001036665A1 Enzyme-containing polymeric sensors |
| 05/25/2001 | WO2001036662A2 Hydrolytic enzyme substrates and assay method |
| 05/25/2001 | WO2001036661A2 Method and apparatus for prokaryotic and eukaryotic cell quantitation |
| 05/25/2001 | WO2001036660A2 Transition metal complexes attached to a polymer via a flexible chain |
| 05/25/2001 | WO2001036659A2 Selectable cell surface marker genes |
| 05/25/2001 | WO2001036658A2 Method for evaluating states of biological systems |
| 05/25/2001 | WO2001036657A2 Altered type ix collagen gene sequences associated with intervertebral disc disease |
| 05/25/2001 | WO2001036645A2 Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same |
| 05/25/2001 | WO2001036641A2 DOUBLE-STRANDED RNA RECEPTOR (dsRNA-R) AND METHODS RELATING THERETO |
| 05/25/2001 | WO2001036640A2 Human fgf-21 gene and gene expression products |
| 05/25/2001 | WO2001036639A2 Bt toxin receptors from lepidopteran insects and methods of use |
| 05/25/2001 | WO2001036638A2 Polypeptides and nucleic acids encoding same |
| 05/25/2001 | WO2001036633A1 Novel protein and dna thereof |
| 05/25/2001 | WO2001036630A2 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same |
| 05/25/2001 | WO2001036626A2 Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds |
| 05/25/2001 | WO2001036624A1 High order nucleic acid based structures |
| 05/25/2001 | WO2001036619A2 Cloning and characterization of the cap gene promoter |
| 05/25/2001 | WO2001036618A2 Transgenic mammals into which a period 1 promoter that confers rhythmical expression has been introduced |
| 05/25/2001 | WO2001036610A1 Human enzymes of the metalloprotease family |
| 05/25/2001 | WO2001036605A2 2786, a human aminopeptidase |
| 05/25/2001 | WO2001036604A2 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| 05/25/2001 | WO2001036602A2 Pak5 a member of the p21-activated kinase (pak) protein family, nucleic acids and methods related to the same |
| 05/25/2001 | WO2001036601A1 Method for the preparation of purified hcv rna by exosome separation |
| 05/25/2001 | WO2001036589A2 Human ex vivo immune system |
| 05/25/2001 | WO2001036487A2 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/25/2001 | WO2001036484A1 New olfactory receptor polypeptides and dna sequences thereof |
| 05/25/2001 | WO2001036482A1 Transgenic mice expressing fluorescent protein under the control of the nestin promoter |
| 05/25/2001 | WO2001036479A1 G-protein coupled receptor |
| 05/25/2001 | WO2001036476A2 Ing2, an iaps associated cell cycle protein, compositions and methods of use |
| 05/25/2001 | WO2001036474A2 Srik a novel cell cycle protein associated with rip3 |
| 05/25/2001 | WO2001036472A2 Compositions and methods for regulating tumor-associated antigen expression |
| 05/25/2001 | WO2001036470A2 Methods and compositions for detection and treatment of breast cancer, based on breast cancer-associated polypeptides |
| 05/25/2001 | WO2001036463A2 Genes specifically expressed in human dendritic cells |
| 05/25/2001 | WO2001036461A2 Compositions and methods for regulating tumor-associated antigen expression |
| 05/25/2001 | WO2001036453A2 Ny-eso-1 nanopeptide derivatives, and uses thereof |
| 05/25/2001 | WO2001036445A1 Compositions and methods for the improved diagnosis and treatment of germ cell tumors |
| 05/25/2001 | WO2001036442A1 Simultaneous detection of hbv, hcv and hiv in plasma samples using a multiplex capture assay |
| 05/25/2001 | WO2001036441A1 Antisense modulation of src-3 expression |
| 05/25/2001 | WO2001036440A1 23 human secreted proteins |
| 05/25/2001 | WO2001036432A2 18 human secreted proteins |
| 05/25/2001 | WO2001036430A1 Transition metal complexes with bidentate ligand having an imidazole ring |
| 05/25/2001 | WO2001035903A2 Compositions and methods for regulating tumor-associated antigen expression |
| 05/25/2001 | WO2001011085A3 Bdnf polymorphism and association with bipolar disorder |
| 05/25/2001 | WO2001009375A3 Inducible screen for drug discovery |
| 05/25/2001 | WO2001007159A3 Integration of biochemical protocols in a continuous flow microfluidic device |
| 05/25/2001 | WO2001006005A3 Diagnostic method comprising wt1 sequences |
| 05/25/2001 | WO2001004349A3 Method for the diagnosis or the prognosis of alzheimer disease therapeutical composition for preventing or treating alzheimer disease |
| 05/25/2001 | WO2001004141A3 Seripancrin |
| 05/25/2001 | WO2001002828A3 Diagnosis of cancer by detecting ash2 polypeptides or polynucleotides |